Gritstone bio Funding: $102M Raised, Series A (2015)

Gritstone bio funding overview

Gritstone bio is based in San Francisco. Gritstone bio has raised $102M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2015. The round record for Gritstone bio runs through 2015; nothing later has been disclosed. Investors on record include Versant Ventures, The Column Group, Clarus Ventures, Frazier Healthcare Partners, Redmile Group, Casdin Capital and 1 others. 7 distinct backers are named across the disclosed rounds.

Gritstone bio at a glance

Total raised: $102M
Latest round: Series A
Latest round date: October 2015
Headquarters: San Francisco
Notable investors: Versant Ventures, The Column Group, Clarus Ventures, Frazier Healthcare Partners, Redmile Group, Casdin Capital, Transformational Healthcare Opportunity

Frequently asked about Gritstone bio funding

How much has Gritstone bio raised?: Gritstone bio has raised $102M in total disclosed funding across the rounds on record.
Who has invested in Gritstone bio?: Versant Ventures, The Column Group, Clarus Ventures, Frazier Healthcare Partners, Redmile Group, Casdin Capital are named among the investors backing Gritstone bio.
What was the latest Gritstone bio funding round?: The most recent disclosed round is a Series A, announced in October 2015.
Where is Gritstone bio based?: Gritstone bio is based in San Francisco.
When did Gritstone bio last raise?: The last disclosed Gritstone bio round closed in October 2015 at Series A.

Gritstone bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Francisco below to benchmark round size and investor mix.

Gritstone bio Funding: $102M Raised, Series A (2015)

Gritstone bio funding overview

Gritstone bio at a glance

Frequently asked about Gritstone bio funding

Companies related to Gritstone bio (36)

Browse related funding lists (10)